Argentina Monoclonal Antibodies Market Size & Outlook

The monoclonal antibodies market in Argentina is expected to reach a projected revenue of US$ 4,805.1 billion by 2030. A compound annual growth rate of 9.1% is expected of Argentina monoclonal antibodies market from 2023 to 2030.
Revenue, 2022 (US$B)
$2,336.4
Forecast, 2030 (US$B)
$4,805.1
CAGR, 2023 - 2030
9.1%
Report Coverage
Argentina

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Argentina monoclonal antibodies market, 2018-2030 (US$B)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Argentina monoclonal antibodies market highlights

  • The Argentina monoclonal antibodies market generated a revenue of USD 2,336.4 billion in 2022 and is expected to reach USD 4,805.1 billion by 2030.
  • The Argentina market is expected to grow at a CAGR of 9.1% from 2023 to 2030.
  • In terms of segment, human was the largest revenue generating source type in 2022.
  • Humanized is the most lucrative source type segment registering the fastest growth during the forecast period.


Monoclonal antibodies market data book summary

Market revenue in 2022USD 2,336.4 billion
Market revenue in 2030USD 4,805.1 billion
Growth rate9.1% (CAGR from 2023 to 2030)
Largest segmentHuman
Fastest growing segmentHumanized
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD billion
Market segmentationHuman, Humanized, Chimeric, Murine


Other key industry trends

  • In terms of revenue, Argentina accounted for 1.1% of the global monoclonal antibodies market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil monoclonal antibodies market is projected to lead the regional market in terms of revenue in 2030.
  • Brazil is the fastest growing regional market in Latin America and is projected to reach USD 17,843.4 billion by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Monoclonal Antibodies Market Companies

Name Profile # Employees HQ Website
Daiichi Sankyo Company, Ltd. (American Regent. Inc.) View profile - - -
Eli Lilly and Company View profile - - -
GlaxoSmithKline PLC View profile - - -
Johnson & Johnson Services, Inc. View profile - - -
Novartis AG View profile - - -
F. Hoffmann-La Roche Ltd. View profile - - -
Bristol Myers Squibb View profile - - -
Novo Nordisk A/S View profile - - -
Viatris Inc View profile 38000 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 https://www.viatris.com
Biogen Inc View profile 7570 225 Binney Street, Cambridge, MA, United States, 02142 https://www.biogen.com
AstraZeneca PLC View profile 89900 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA https://www.astrazeneca.com
Bayer AG View profile 99723 Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 https://www.bayer.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com
Amgen Inc View profile 26700 One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 https://www.amgen.com

Argentina monoclonal antibodies market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to monoclonal antibodies market will help companies and investors design strategic landscapes.


Human was the largest segment with a revenue share of 59.91% in 2022. Horizon Databook has segmented the Argentina monoclonal antibodies market based on human, humanized, chimeric, murine covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Argentina monoclonal antibodies market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Argentina monoclonal antibodies market databook

  • Our clientele includes a mix of monoclonal antibodies market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Argentina monoclonal antibodies market , including forecasts for subscribers. This country databook contains high-level insights into Argentina monoclonal antibodies market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Argentina monoclonal antibodies market size, by source type, 2018-2030 (US$B)

Argentina Monoclonal Antibodies Market Outlook Share, 2022 & 2030 (US$B)

Argentina monoclonal antibodies market size, by source type, 2018-2030 (US$B)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online